JP2008511597A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511597A5
JP2008511597A5 JP2007528961A JP2007528961A JP2008511597A5 JP 2008511597 A5 JP2008511597 A5 JP 2008511597A5 JP 2007528961 A JP2007528961 A JP 2007528961A JP 2007528961 A JP2007528961 A JP 2007528961A JP 2008511597 A5 JP2008511597 A5 JP 2008511597A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
azetidinesulfonamide
difluorophenyl
methylpropyl
pyrimidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007528961A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511597A (ja
JP4795352B2 (ja
Filing date
Publication date
Priority claimed from GB0419235A external-priority patent/GB0419235D0/en
Priority claimed from GB0502544A external-priority patent/GB0502544D0/en
Application filed filed Critical
Priority claimed from PCT/GB2005/003257 external-priority patent/WO2006024823A1/en
Publication of JP2008511597A publication Critical patent/JP2008511597A/ja
Publication of JP2008511597A5 publication Critical patent/JP2008511597A5/ja
Application granted granted Critical
Publication of JP4795352B2 publication Critical patent/JP4795352B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007528961A 2004-08-28 2005-08-23 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体 Expired - Lifetime JP4795352B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0419235A GB0419235D0 (en) 2004-08-28 2004-08-28 Compounds
GB0419235.7 2004-08-28
GB0502544A GB0502544D0 (en) 2005-02-08 2005-02-08 Compounds
GB0502544.0 2005-02-08
PCT/GB2005/003257 WO2006024823A1 (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011013745A Division JP5364735B2 (ja) 2004-08-28 2011-01-26 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体

Publications (3)

Publication Number Publication Date
JP2008511597A JP2008511597A (ja) 2008-04-17
JP2008511597A5 true JP2008511597A5 (enExample) 2011-03-17
JP4795352B2 JP4795352B2 (ja) 2011-10-19

Family

ID=35549576

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007528961A Expired - Lifetime JP4795352B2 (ja) 2004-08-28 2005-08-23 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体
JP2011013745A Expired - Lifetime JP5364735B2 (ja) 2004-08-28 2011-01-26 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体
JP2013120663A Expired - Lifetime JP5730350B2 (ja) 2004-08-28 2013-06-07 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011013745A Expired - Lifetime JP5364735B2 (ja) 2004-08-28 2011-01-26 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体
JP2013120663A Expired - Lifetime JP5730350B2 (ja) 2004-08-28 2013-06-07 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体

Country Status (27)

Country Link
US (5) US7838675B2 (enExample)
EP (3) EP2311827A1 (enExample)
JP (3) JP4795352B2 (enExample)
KR (1) KR101280095B1 (enExample)
CN (1) CN102796081B (enExample)
AR (1) AR050617A1 (enExample)
AU (1) AU2005279045B2 (enExample)
BR (1) BRPI0514735B8 (enExample)
CA (1) CA2578441C (enExample)
CY (1) CY1114803T1 (enExample)
DK (1) DK1809624T3 (enExample)
ES (1) ES2442678T3 (enExample)
HR (1) HRP20140023T1 (enExample)
IL (1) IL181241A0 (enExample)
ME (1) ME01620B (enExample)
MX (1) MX2007002240A (enExample)
MY (1) MY148125A (enExample)
NO (1) NO338749B1 (enExample)
NZ (1) NZ553335A (enExample)
PL (1) PL1809624T3 (enExample)
PT (1) PT1809624E (enExample)
RS (1) RS53145B (enExample)
RU (1) RU2408587C2 (enExample)
SI (1) SI1809624T1 (enExample)
TW (1) TWI369983B (enExample)
UY (1) UY29085A1 (enExample)
WO (1) WO2006024823A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6262286A (ja) * 1985-09-13 1987-03-18 株式会社東芝 沸騰水型原子炉炉心
GB0217431D0 (en) 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
RU2395503C2 (ru) 2004-05-19 2010-07-27 Зольвай Фармасьютиклз Гмбх Лекарственные средства, содержащие n-сульфамоил-n'-арилпиперазины, предназначенные для профилактики или лечения ожирения и связанных с ним состояний
RU2408587C2 (ru) 2004-08-24 2011-01-10 Астразенека Аб Производные пиримидинсульфонамида в качестве модуляторов рецепторов хемокинов
JP2008540539A (ja) 2005-05-10 2008-11-20 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャンネルの調節因子としての二環系誘導体
EP2099444A4 (en) 2006-12-14 2012-11-07 Nps Pharma Inc USE OF D-SERIN DERIVATIVES FOR THE TREATMENT OF ANTIBODIES
US20100137398A1 (en) * 2007-05-04 2010-06-03 Novartis Ag Use of hdac inhibitors for the treatment of gastrointestinal cancers
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
KR20110031462A (ko) * 2008-07-16 2011-03-28 아스트라제네카 아베 피리미딜 술폰아미드 유도체 및 케모카인 매개 질환의 치료를 위한 그의 용도
CA2762680C (en) 2009-05-21 2018-04-17 Chlorion Pharma, Inc. Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
AR080375A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida
WO2012007748A1 (en) * 2010-07-13 2012-01-19 Astrazeneca Ab New crystalline forms of n-[2-[[(2,3-difluoropheny)methyl)thio]-6-{[(1r,2s)-2,3-dihydroxy-1- methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide
MX342874B (es) 2011-07-12 2016-10-17 Astrazeneca Ab N-(6-((2r,3s)-3,4-dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pi rimidin-4-il)-3-metilacetidina-1-sulfonamida como modulador del receptor de quimiocina.
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物
PT3263133T (pt) 2015-02-27 2020-05-21 Univ Kyushu Nat Univ Corp Composto de piridinona e a sua utilização
EP3426253A4 (en) * 2016-03-11 2019-11-06 Ardea Biosciences, Inc. CXCR-2 INHIBITORS FOR THE TREATMENT OF CRYSTALARTHROPATHIES
US10660909B2 (en) 2016-11-17 2020-05-26 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
WO2019165315A1 (en) 2018-02-23 2019-08-29 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists alone or in combination
WO2023028077A1 (en) 2021-08-24 2023-03-02 Genentech, Inc. Sodium channel inhibitors and methods of designing same

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540356A (en) * 1949-03-12 1951-02-06 Sharp & Dohme Inc Sulfonamide derivatives
GB866843A (en) * 1958-12-08 1961-05-03 Ici Ltd Sulphonamidopyrimidines
NL279406A (enExample) * 1961-06-16
NL127990C (enExample) 1962-12-29
US3457278A (en) * 1964-10-15 1969-07-22 Geigy Chem Corp Cyclopropyl-4-sulfanilamido-pyrimidines
US3452018A (en) * 1966-08-29 1969-06-24 American Home Prod 1 - (2 - substituted - 6 - arylsulfonamidopyrimidin - 4 - yl)pyridinium hydroxide inner salts
US3673184A (en) * 1970-09-02 1972-06-27 Dainippon Pharmaceutical Co Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives
JPS61118372A (ja) 1984-11-12 1986-06-05 Nippon Mektron Ltd 新規ピリミジン誘導体およびその製造法
JPS6442295A (en) 1987-08-10 1989-02-14 Seiko Epson Corp Memory card mounting structure
JPH03197467A (ja) 1989-12-26 1991-08-28 Nippon Kayaku Co Ltd ピリミジノン誘導体その製法及びそれを有効成分とする殺虫・殺ダニ剤
JPH05505609A (ja) 1990-03-30 1993-08-19 メルク・エンド・カムパニー・インコーポレーテツド 置換ピリミジン、ピリミジノンおよびピリドリミジン
RU2083567C1 (ru) * 1991-04-25 1997-07-10 Ф.Хоффманн-Ля Рош Аг Производные арилсульфонамида или их соли и фармацевтическая композиция, проявляющая ангиопротекторное, антигипертензивное и вазоспазмолитическое, в частности противоишемическое, действие
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Ｖｅｇｆインヒビターとしてのキナゾリン誘導体
ATE211134T1 (de) 1996-03-05 2002-01-15 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
BR9908004A (pt) 1998-02-17 2001-12-18 Tularik Inc Composto, composição e método para prevençãoou supressão de uma infecção viral
SE9802729D0 (sv) 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
WO2000076980A1 (en) 1999-06-10 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
SE9903544D0 (sv) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
EP1257555B1 (en) * 2000-02-11 2003-12-03 AstraZeneca AB Pyrimidine compounds and their use as modulators of chemokine receptor activity
GB2359078A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
CA2410562A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
JP2004509874A (ja) 2000-09-25 2004-04-02 アクテリオン　ファマシューティカルズ　リミテッド 新規なアリールアルカン−スルフォンアミド類
AU2002258400A1 (en) 2001-02-16 2002-08-28 Tularik Inc. Methods of using pyrimidine-based antiviral agents
WO2003040131A1 (en) * 2001-11-07 2003-05-15 F. Hoffmann-La Roche Ag Aminopyrimidines and pyridines
TWI328007B (en) 2002-01-16 2010-08-01 Astrazeneca Ab Novel compounds
AR038703A1 (es) 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
GB0217431D0 (en) 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
WO2004018435A1 (en) 2002-08-24 2004-03-04 Astrazeneca Ab Pyrimidine derivatives as modulators of chemokine receptor activity
RU2408587C2 (ru) 2004-08-24 2011-01-10 Астразенека Аб Производные пиримидинсульфонамида в качестве модуляторов рецепторов хемокинов
KR20110031462A (ko) 2008-07-16 2011-03-28 아스트라제네카 아베 피리미딜 술폰아미드 유도체 및 케모카인 매개 질환의 치료를 위한 그의 용도

Similar Documents

Publication Publication Date Title
JP2008511597A5 (enExample)
JP2006526031A5 (enExample)
JP2021191784A5 (enExample)
JP2007522220A5 (enExample)
JP2005518413A5 (enExample)
JP2009511595A5 (enExample)
JP2009502743A5 (enExample)
JP2009545527A5 (enExample)
JP2009535352A5 (enExample)
JP2009502793A5 (enExample)
JP2010526777A5 (enExample)
JP2007302689A5 (enExample)
JP2020097577A5 (enExample)
JP2009501177A5 (enExample)
JP2009501178A5 (enExample)
JP2005508905A5 (enExample)
JP2010077141A5 (enExample)
JP2007537301A5 (enExample)
JP2007524683A5 (enExample)
JP2008513510A5 (enExample)
EP2404912A3 (en) Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds
JP2012507535A5 (enExample)
EP2292209A3 (en) Stable pharmaceutical composition comprising a pyramidine-sulfamide
EP2189439A3 (en) CaSR antagonist
JP2005538089A5 (enExample)